Source: PRWeb

Press Release: Day Zero Diagnostics : Day Zero Diagnostics Wins the New Life Sciences Diagnostic Category at the Annual UCSF Health Awards

Pioneering a New Class of Culture-free, Sequencing Diagnostics to Help Patients with Severe Infections(PRWeb October 11, 2021)Read the full story at https://www.prweb.com/releases/day_zero_diagnostics_wins_the_new_life_sciences_diagnostic_category_at_the_annual_ucsf_health_awards/prweb18252697.htm

Read full article »

Day Zero Diagnostics's Competitors | Day Zero Diagnostics's News | Day Zero Diagnostics's Financials

Followers on Owler

170

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

President & CEO

Jong Lee

CEO Approval Rating

88/100

DZD is a Massachusetts-based biotechnology company that offers solutions such as infectious disease diagnosis and genomic sequencing for bloodstream infections.